Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy

Not Applicable

Completed

• Conditions: Depressive Symptoms; Anxiety States, Neurotic
• Interventions: Behavioral: Continuous Self Feedback; Behavioral: Continuous Client Feedback

• Registration Number: NCT02656641
• Lead Sponsor: Christiana Care Health Services

Brief Summary

This study will assess the effects of client feedback, using the Patient Health Questionnaire - 9 and Generalized Anxiety Disorder 7-Item Scale, on depression and anxiety in individuals undergoing brief psychotherapy. Client feedback allows therapists to monitor treatment progress in real time. Identifying an easily accessible treatment intervention, which utilizes commonly used scales, that potentially enhances the effect of brief psychotherapy and improves treatment outcomes is a valuable endeavor with clear implications for therapy practices. It is hypothesized that clients who complete these scales each session will show greater symptom improvement than clients who do not complete the scales.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11
• Study First Submitted: 2015-11-25
• Study First Submitted QC: 2016-01-13
• Study First Posted: 2016-01-15
• Primary Completion: 2016-08-31
• Study Completion: 2016-08-31
• Status Verified: 2017-07
• Last Update Submitted: 2017-07-18
• Last Update Posted: 2017-07-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 81

Inclusion Criteria

• Diagnosis of Major Depressive Disorder, Generalized Anxiety Disorder, or Adjustment Disorder

Exclusion Criteria

• Require a higher level of care than brief psychotherapy, or have been diagnosed with an intellectual disability, personality disorder, substance use disorder, or major medical illness

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Continuous Self Feedback	Continuous Self Feedback	Clients will complete symptom and quality of life scales before their first session and before their last or tenth session, whichever occurs first. Clients will then complete symptoms scales, specifically the Patient Health Questionnaire-9 and Generalized Anxiety Disorder 7-Item Scale before each other session. The treating clinician will not have access to these results.
Continuous Client Feedback	Continuous Client Feedback	Clients will complete symptom and quality of life scales before their first session and before their last or tenth session, whichever occurs first. Clients will then complete symptoms scales, specifically the Patient Health Questionnaire-9 and Generalized Anxiety Disorder 7-Item Scale before each other session. The treating clinician will review and discuss their results and at the beginning of each session.

Primary Outcome Measures

Name	Time	Method
Change in depressive symptoms as assessed by Patient Health Questionnaire-9	Baseline and end of treatment up to 10 weeks	Assesses depressive symptoms
Change in anxiety symptoms as assessed by Generalized Anxiety Disorder 7-Item Scale	Baseline and end of treatment up to 10 weeks	Assesses anxiety symptoms

Secondary Outcome Measures

Name	Time	Method
World Health Organization - Quality of Life BREF Scale	Baseline and end of treatment up to 10 weeks	Assesses domains of physical health, psychological health, social relationships, and environment
Schwartz Outcome Scale	Baseline and end of treatment up to 10 weeks	Monitors treatment outcomes

Trial Locations

Locations (1)

Christiana Care Health System - Adult Bridge Program; 🇺🇸 Wilmington, Delaware, United States